Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor
- 31 August 1996
- Vol. 120 (2), 449-454
- https://doi.org/10.1016/s0039-6060(96)80322-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in VitroBiochemical and Biophysical Research Communications, 1994
- Matrix-bound thrombospondin promotes angiogenesis in vitroThe Journal of cell biology, 1994
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- The thrombospondin familyCurrent Biology, 1993
- Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.The Journal of cell biology, 1990
- Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cellsClinical & Experimental Metastasis, 1989
- Thrombospondin in malignant and non-malignant breast tissueEuropean Journal of Cancer and Clinical Oncology, 1989
- Thrombospondin-induced adhesion of human keratinocytes.Journal of Clinical Investigation, 1988
- Thrombospondin Promotes Cell-Substratum AdhesionScience, 1987
- Synthesis and secretion of thrombospondin by cultured human endothelial cells.The Journal of cell biology, 1982